These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12172891)

  • 1. Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene.
    Haufroid V; Buchet JP; Gardinal S; Lison D
    Int Arch Occup Environ Health; 2002 Sep; 75(7):453-8. PubMed ID: 12172891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the CYP2E1 genotype and phenotype for the biological monitoring of occupational exposure to styrene.
    Prieto-Castelló MJ; Cardona A; Marhuenda D; Roel JM; Corno A
    Toxicol Lett; 2010 Jan; 192(1):34-9. PubMed ID: 20117323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo CYP2E1 phenotyping as a new potential biomarker of occupational and experimental exposure to benzene.
    Piccoli P; Carrieri M; Padovano L; Di Mare M; Bartolucci GB; Fracasso ME; Lepera JS; Manno M
    Toxicol Lett; 2010 Jan; 192(1):29-33. PubMed ID: 19900514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cytochrome P4502E1 (CYP2E1) activity and hepatic and lymphocyte mRNA expression in patients with chronic hepatitis C.
    Haufroid V; Ligocka D; Wallemacq P; Lison D; Horsmans Y
    Toxicol Lett; 2005 Jan; 155(1):171-7. PubMed ID: 15585372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
    Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
    Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.
    Albertini RJ; Sram RJ; Vacek PM; Lynch J; Rossner P; Nicklas JA; McDonald JD; Boysen G; Georgieva N; Swenberg JA
    Chem Biol Interact; 2007 Mar; 166(1-3):63-77. PubMed ID: 16949064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.
    Khemawoot P; Nishino K; Ishizaki J; Yokogawa K; Miyamoto K
    Eur J Pharmacol; 2007 Nov; 574(1):71-6. PubMed ID: 17651723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
    Eap CB; Schnyder C; Besson J; Savary L; Buclin T
    Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
    Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
    Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of genetic polymorphisms of drug-metabolizing enzymes for the interpretation of biomarkers of exposure to styrene.
    Haufroid V; Buchet JP; Gardinal S; Ghittori S; Imbriani M; Hirvonen A; Lison D
    Biomarkers; 2001; 6(3):236-49. PubMed ID: 23886278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interest of genotyping and phenotyping of drug-metabolizing enzymes for the interpretation of biological monitoring of exposure to styrene.
    Haufroid V; Jakubowski M; Janasik B; Ligocka D; Buchet JP; Bergamaschi E; Manini P; Mutti A; Ghittori S; Arand M; Hangen N; Oesch F; Hirvonen A; Lison D
    Pharmacogenetics; 2002 Dec; 12(9):691-702. PubMed ID: 12464798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic repeat polymorphism in the regulating region of CYP2E1: frequency and relationship with enzymatic activity in alcoholics.
    Plee-Gautier E; Foresto F; Ferrara R; Bodénez P; Simon B; Manno M; Berthou F; Lucas D
    Alcohol Clin Exp Res; 2001 Jun; 25(6):800-4. PubMed ID: 11410713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone.
    Marchand LL; Wilkinson GR; Wilkens LR
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):495-500. PubMed ID: 10385138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats.
    Khemawoot P; Yokogawa K; Shimada T; Miyamoto K
    Biochem Pharmacol; 2007 Jan; 73(1):155-62. PubMed ID: 17049493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiologic study.
    Albertini RJ; Srám RJ; Vacek PM; Lynch J; Nicklas JA; van Sittert NJ; Boogaard PJ; Henderson RF; Swenberg JA; Tates AD; Ward JB; Wright M; Ammenheuser MM; Binkova B; Blackwell W; de Zwart FA; Krako D; Krone J; Megens H; Musilová P; Rajská G; Ranasinghe A; Rosenblatt JI; Rössner P; Rubes J; Sullivan L; Upton P; Zwinderman AH
    Res Rep Health Eff Inst; 2003 Jun; (116):1-141; discussion 143-62. PubMed ID: 12931846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes.
    Kim YC; Kim YG; Kim EJ; Cho MK; Kim SG; Lee MG
    Biopharm Drug Dispos; 2003 Mar; 24(2):53-61. PubMed ID: 12619050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of genetic polymorphisms of styrene-metabolizing enzymes on the levels of urinary biomarkers of styrene exposure.
    Carbonari D; Mansi A; Proietto AR; Paci E; Bonanni RC; Gherardi M; Gatto MP; Sisto R; Tranfo G
    Toxicol Lett; 2015 Mar; 233(2):156-62. PubMed ID: 25562543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
    Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
    Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of CYP2E1 activity in diabetic rat model].
    Li L; Zhang Y
    Yao Xue Xue Bao; 1998 Dec; 33(12):891-5. PubMed ID: 12016852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms.
    Kim RB; O'Shea D
    Clin Pharmacol Ther; 1995 Jun; 57(6):645-55. PubMed ID: 7781264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.